Frequently Asked Questions - July 2010

Q1.

When and where was Progen Pharmaceuticals Limited (Progen) incorporated?

Progen, formerly Progen Industried Limited,  was incorporated on 26 September 1989 in the State of Queensland, Australia.

Q2.

What companies are in the Progen Group?  

Q3.

On what exchanges is Progen listed?

Progen is dual listed on the Australian Securities Exchange (ASX:PGL) and the US OTC Market (OTC: PGLA).

Q4.

Where is Progen located?

Progen’s head office is at 16 Benson Street, Toowong, Qld, Australia and has offices in San Francisco and North Carolina. The PharmaSynth manufacturing facility is located at: 2806 Ipswich Road, Darra, QLD, Australia.

Q5.

Who are the members of Progen’s Board of Directors? 

Mr Stuart James - Chairman
Dr Julie Cherrington - Non-Executive Director 
Dr Paul Lin - Non-Executive Director 
Mr Heng Hsin Tang - Non-Executive Director 
Dr John Chiplin  - Non-Executive Director 
Mr Thomas Burt - Non-Executive Director 

Q6.

Who are the members of Progen’s Senior Management? 

Mrs Sue MacLeman –  CEO 
Dr Laurence Marton – Chief Scientific Officer
Mr Paul Dixon - General Manager Finance
Dr Ian Bytheway - Director Research & Development
Dr Keith Dedge - Director Preclinical Development
Mr Darryn Bampton - Director Regulatory Affairs
Ms Fleur Lankesheer - Director Legal & Business Development

Q7.

How many employees does Progen have?

Currently 25 employees (full and part-time)

Q8.

When does Progen’s financial year end?

30 June

Q9.

What are the contact details for Progen’s share registry?

Australia
Computershare Investor Service Pty Ltd
Level 19, 307 Queen Street,
Brisbane, Qld, 4000
T 1300 552 270
www.computershare.com.au  

United States
Computershare Trust Company
350 Indiana Street
Suite 750, Golden CO 80401
T +303 262 0600
www.computershare.com        

Q10.

When does the Progen hold its Annual General Meeting (AGM)?

Generally in late November of each year.

Q11.

How can I get a copy of Progen Annual Report?

You can find our annual reports here. Alternatively, you can contact Progen to have a hard copy mailed to you.

Q12.

What is the number of listed shares and options currently outstanding? 

24,709,097 shares, 2,970,538 listed options and 459,000 unlisted options.

Q13.

Who are Progen’s Auditors?

Ernst & Young
Level 5, Waterfront Place
1 Eagle Street
Brisbane, Qld, 4000
Australia